glivec comprimate filmate 100 mg
novartis pharma ag - imatinibum - comprimate filmate - 100 mg
glivec comprimate filmate 400 mg
novartis pharma ag - imatinibum - comprimate filmate - 400 mg
nimid forte comprimate 100 mg + 2 mg
kusum healthcare pvt.ltd - nimesulidum + tizanidinum - comprimate - 100 mg + 2 mg
asist 200 mg/5 ml granule pentru sirop
bilim pharmaceuticals a.Ș. - acetylcysteinum - granule pentru sirop - 200 mg/5 ml
asist plus 600 mg/3 g granule pentru soluţie orală
bilim pharmaceuticals a.Ș. - acetylcysteinum - granule pentru soluţie orală - 600 mg/3 g
mekinist
novartis europharm limited - trametinib - melanomul - agenți antineoplazici - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 și 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non-cancer pulmonar cu celule mici (nsclc)trametinib în combinație cu dabrafenib este indicat pentru tratamentul pacienților adulți cu avansate non-cancer pulmonar cu celule mici, cu o mutație braf v600.
ibuprofen 200 mg capsule moi
apotex inc. - ibuprofenum - capsule moi - 200 mg
ibuprofen 400 mg capsule moi
apotex inc. - ibuprofenum - capsule moi - 400 mg
rhinobos 160 mg + 1 mg + 2,5 mg sirop
bosnalijek, pharmaceutical and chemical industry jsc - paracetamolum + chlorphenaminum + phenylephrinum - sirop - 160 mg + 1 mg + 2,5 mg
rhinobos 325 mg + 2 mg + 5 mg comprimate
bosnalijek, pharmaceutical and chemical industry jsc - paracetamolum + chlorphenaminum + phenylephrinum - comprimate - 325 mg + 2 mg + 5 mg